H15.11
Episcleritis periodica fugax
Clinical Classification Guidelines
Medical Intelligence & Overview
Episcleritis periodica fugax is a rare eye condition characterized by transient episodes of inflammation affecting the episcleral layer of the eye. This condition often presents as quick, recurrent episodes that resolve on their own, typically without long-term damage. It is important to distinguish this condition from other eye inflammations to ensure proper management and to address any underlying issues. While generally benign, episodic episodes can cause discomfort and concern among patients. Recognizing the signs, causes, and available treatments can help mitigate symptoms and improve quality of life.
Causes & Symptoms
Clinical Causes: Autoimmune responses leading to inflammation Unknown factors, as exact causes remain unclear Potential association with systemic autoimmune diseases, such as rheumatoid arthritis or lupus Environmental triggers, like exposure to allergens or irritants Repeated episodes could be linked to vascular or inflammatory pathways
Key Symptoms: Sudden, brief episodes of eye redness Mild to moderate ocular discomfort or irritation Transient swelling or a feeling of fullness in the affected eye Episodes typically affect one eye at a time No significant vision loss usually occurs Episodes resolve spontaneously within hours to a few days
Diagnostic & Treatment
Diagnosis Path: Diagnosis primarily involves a thorough eye examination by an eye care professional. The clinician will observe the characteristic appearance of episcleritis, which appears as a localized, sectoral redness of the sclera. Additional diagnostic tools may include:
Treatment Protocols: Management of episodic episodes often focuses on alleviating symptoms and preventing future occurrences. Since episodes tend to resolve on their own, treatment may include:
Clinical Advice & FAQs
Billing Guidance
Is H15.11 a billable ICD-10 code?
Yes, H15.11 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H15.11?
Clinical documentation must specify the nature of Episcleritis periodica fugax and any associated comorbidities for accurate reporting.
Cite this Clinical Reference